These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 2547468)
21. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis. Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414 [TBL] [Abstract][Full Text] [Related]
22. [Guideline for prevention of RhD alloimmunizationin RhD negative women]. Lubušký M; Procházka M; Simetka O; Holusková I Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977 [TBL] [Abstract][Full Text] [Related]
23. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given? Bowman JM Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267 [TBL] [Abstract][Full Text] [Related]
24. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland. Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198 [TBL] [Abstract][Full Text] [Related]
25. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed? Howard HL; Martlew VJ; McFadyen IR; Clarke CA Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694 [TBL] [Abstract][Full Text] [Related]
26. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies. Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781 [TBL] [Abstract][Full Text] [Related]
27. In vivo studies of monoclonal anti-D and the mechanism of immune suppression. Kumpel BM Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904 [TBL] [Abstract][Full Text] [Related]
28. Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: A retrospective nationwide cohort study. Jernman R; Isaksson C; Haimila K; Kuosmanen M; Mäkikallio-Anttila K; Toivonen S; Ordén MR; Sulin K; Tihtonen K; Vääräsmäki M; Sainio S Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1868-1875. PubMed ID: 34157128 [TBL] [Abstract][Full Text] [Related]
29. [Advantages of preventing Rh isoimmunization]. Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466 [TBL] [Abstract][Full Text] [Related]
34. Rh isoimmunization during pregnancy: antenatal prophylaxis. Bowman JM; Chown B; Lewis M; Pollock JM Can Med Assoc J; 1978 Mar; 118(6):623-7. PubMed ID: 77714 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant]. L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042 [TBL] [Abstract][Full Text] [Related]
36. Why women are not receiving anti-Rh prophylaxis. Tovey LA Br Med J (Clin Res Ed); 1987 Feb; 294(6570):508. PubMed ID: 3030482 [No Abstract] [Full Text] [Related]
37. ACOG releases report on prevention of D isoimmunization. Am Fam Physician; 1991 Jan; 43(1):307-8, 310. PubMed ID: 1846056 [No Abstract] [Full Text] [Related]
38. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749 [TBL] [Abstract][Full Text] [Related]
39. Should anti-D immunoglobulin be given antenatally? Tovey GH Lancet; 1980 Aug; 2(8192):466-8. PubMed ID: 6106109 [TBL] [Abstract][Full Text] [Related]
40. A case for the antenatal administration of anti-D immunoglobulin to primigravidae. Tovey LA; Taverner JM Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]